Hardman & Co Monthly: Advanced Oncotherapy, Allergy Therapeutics, Alliance Pharma, Burford Capital, Purplebricks Group & United Cacao Limited SEZC

In this months Hardman & Co report the feature article is “Survey shows underlying strengths in wealth manager business models” By Keith Hiscock, C.E.O.

Hardman & Co ReportThe survey recently published by ComPeer of wealthy investors has some surprising results. Only slightly more than 10% of those with £1 million plus (high net worths or HNWs) to invest, inherited the money. The young are no better advised than their parents, with 25% of HNWs taking no advice. Wealth managers are attractive to investors for four reasons. First, there are plenty of ‘non-advised rich’ to target as new clients. Second, wealth managers’ assets are very sticky with 74% of 50+ year olds having been with the same manager for at least 5 years. Third, all age groups far prefer face to face meetings, rather than the internet or social media for contact, suggesting commentators overemphasise the threat from new media. Fourth, fees are only the third most important criteria in choosing an advisor. All the more surprising then that these advisors are poor at following relationships through a family; even among those with £1million plus to invest, only 19% get a call from their parents’ advisors!

Other topics cover companies:

Advanced Oncotherapy PLC (LON:AVO)
Allergy Therapeutics PLC (LON:AGY)
Alliance Pharma Plc (LON:APH)
Burford Capital Limited (LON:BUR)
City of London Investment Group Plc (LON:CLIG)
Empresaria Group Plc (LON:EMR)
Grafenia Plc (LON:GRA)
Lombard Risk Management Plc (LON:LRM)
MedicX Fund Ltd. (LON:MXF)
Murgitroyd Group Plc (LON:MUR)
Primary Health Properties Plc (LON:PHP)
PPHE Hotel Group Ltd (LON:PPH)
Purplebricks Group Plc (LON:PURP)
R.E.A. Holdings (LON:RE.)
Real Good Food PLC (LON:RGD)
Tethys Oil AB (LON:TETY)
United Cacao Limited SEZC (LON:CHOC)
Verona Pharma Plc (LON:VRP)

Click to view all articles for the EPIC: , , ,
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Hardman & Co

More articles like this

Hardman & Co

Advanced Oncotherapy: Understanding the significance of 230MeV

Advanced Oncotherapy plc (LON:AVO) goal is to deliver an affordable and novel PT system, called LIGHT, based on state-of-the-art technology, developed originally at the world-renowned CERN. The complex assembly of the first LIGHT accelerator in Daresbury

Allergens dominate UK food recalls, finds study

More than half of food recalls in the United Kingdom over a 5-year period were due to allergens, according to a recently released study. Allergen-related recalls increased annually until 2019, peaking at 118 before decreasing to

Allergy Therapeutics welcomes new Non-Executive Directors

Allergy Therapeutics announced the appointments of Anthony Parker and Simon Shen to its Board as Non-Executive Directors effective immediately. “I would like to welcome Anthony and Simon. Southern Fox and ZQ Capital have been long-standing and supportive shareholders of Allergy

Allergy Therapeutics updates on its clinical programmes

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has announced that the first subject has been dosed in the pivotal Phase III G306 trial, to evaluate the efficacy and safety of

Allergy Therapeutics appoints two Non-Executive Directors

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has today announced the appointments of Anthony Parker and Zheqing (Simon) Shen as Non-Executive Directors of the Company, with immediate effect. Anthony represents

Allergies and Thanksgiving

As Thanksgiving and other holiday celebrations bring people around the table, Intermountain Healthcare dietitians say it’s crucial to take food allergies into consideration when planning the big meal. “A response to an allergic reaction can be

Allergy Therapeutics appoints Martin Hopcroft as interim CFO

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has announced the appointment of Martin Hopcroft to the role of Interim Chief Financial Officer (CFO). Martin will report into Chief Executive

Food business operator fined for allergy breach

A food business operator based in Newcastle, England has been fined in court after serving a dish containing peanuts to a woman with a peanut allergy, resulting in her being hospitalised. According to the Food Standards

Are restaurants taking allergies seriously?

In an engaging panel held at Twickenham Stadium as part of New Food’s Food Safety Conference 2022, experts came together to debate whether food allergy regulations in restaurants are sufficient. Here’s the highlights. Are restaurant allergy